The aim of this study was to compare maternal serum VEGF and NT-proBNP-levels in women with different degrees of AIP and a high share of women with placenta percreta and to test whether these biomarker levels can predict the clinical degree of invasion. The gene discussed is NPPB; the disease is autoimmune pancreatitis.